Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism
The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...
Main Authors: | Xin Qiao, Zhuo-Chao Zhou, Rui Niu, Yu-Tong Su, Yue Sun, Hong-Lei Liu, Jia-Lin Teng, Jun-Na Ye, Hui Shi, Cheng-De Yang, Xiao-Bing Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00855/full |
Similar Items
-
Atherogenic dyslipidemia and insulin resistance associated with nonalcohol hepatic steatosis: comparison, contrast, and differentiated therapy
by: L. B. Lazebnik, et al.
Published: (2009-06-01) -
Role of the Gut Microbiota in the Development of Lipid and Carbohydrate Metabolism in the Liver Steatosis in Children
by: N.Yu. Zavgorodnya, et al.
Published: (2016-11-01) -
Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
by: Yu-Cheng Li, et al.
Published: (2018-08-01) -
Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
by: Ting-Chen Chang, et al.
Published: (2019-12-01) -
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
by: Li Y, et al.
Published: (2017-09-01)